A Free Webinar From The Brain & Behavior Research Foundation Webinar Host Jeffrey Borenstein, M.D. Webinar Presenter Conor ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

The link between diet and depression is a critical area of research. It could lead to finding effective strategies to treat depression. A study found that mice who consumed a high-salt diet developed ...

During the year-end holiday season, the suicide rate declines, U.S. health statistics show. The month of December typically has the year's lowest average daily suicide rate. Yet each year at this time ...

PHILADELPHIA— Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health ...

Depression is a debilitating psychiatric disorder characterized by one or more depressive bouts lasting for at least two weeks and resulting in a depressed mood, lack of interest in pleasurable ...

Two new studies found that the popular weight loss and diabetes drug semaglutide, sold under the brand names Ozempic and Wegovy, does not increase the risk of depression and suicide. millaf - ...

It's common for teenagers go through emotional ups and downs and do things that don't seem rational. Learn the two hallmark ...

Whether you struggle with anxiety, depression, self-esteem, or any other issue, you should know that there is hope for a better tomorrow. You might be initially hesitant to seek out help and support ...